The issue is now over $1.00 lower than it was when the deal between the pharmacies was first announced. On Oct. 27, 2015, the issue rallied from its previous day close of $6.08 to $8.67, which was just shy of the proposed $9.00 take-out price.
Now the deal is all but dead, there has been massive liquidation in the issue. Its six-day losing streak (including Wednesday's price action), has taken the issue as low as $4.80 and is not far off that level.
That takes the issue back to prices not seen since October 2014, when it bottomed at $4.42.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.